Structure-based identification of a major neutralizing site in an adenovirus hexon.
about
Circumventing antivector immunity: potential use of nonhuman adenoviral vectorsBovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implicationsReplacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.Structure-based high-throughput epitope analysis of hexon proteins in B and C species human adenoviruses (HAdVs)Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.Current progress in the development of a prophylactic vaccine for HIV-1.Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regionsIdentification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein.Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectorsHexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.Molecular epidemiology of hydropericardium syndrome outbreak-associated serotype 4 fowl adenovirus isolates in central ChinaOvercoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.Molecular characterisation of fowl adenovirus type 7 isolated from poultry associated with inclusion body hepatitis in Poland.Advances and future challenges in adenoviral vector pharmacology and targeting.Latest insights on adenovirus structure and assembly.Hydropericardium syndrome: current state and future developments.Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.Adenoviral vector-based strategies against infectious disease and cancer.Directed evolution of mutator adenoviruses resistant to antibody neutralization.Fowl adenovirus serotype 4: Epidemiology, pathogenesis, diagnostic detection, and vaccine strategies.Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer.Phylogenetic and geographic analysis of fowl adenovirus field strains isolated from poultry in Poland.Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients.Interaction of human enterochromaffin cells with human enteric adenovirus 41 leads to serotonin release and subsequent activation of enteric glia cells.Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer.
P2860
Q26995655-A719DC90-FDB2-484E-A8C6-16F363D50BC0Q30229074-44108583-EBCF-4D7C-B2B4-6A2EBDDFDACFQ33469751-39E42995-74EA-4935-BE25-26A3AB084FDFQ34162092-C96A6893-F3E8-469D-B81B-8449FAAF4C86Q34200191-FA81B8B6-BAEE-4D2A-A5EB-740DB095430CQ34358402-999880F9-7254-437E-9A75-5DDD9ADE0345Q34502108-792B912E-6953-4165-B371-264FFB1FFBBAQ35308252-130A6D68-70EA-4785-A108-8B5EBE13ABF8Q36171914-FC5F5E30-F200-4F83-94BB-C592D6B8F337Q36246676-175CEF5A-8D29-44EC-A9AF-94757ACB0169Q36347381-1832AD47-AB16-4840-93E8-718AE5F24F3EQ36645405-8FA86A3A-D960-40A4-84E9-92B6BE156D89Q36659279-FAA7C8D8-7027-45D5-A22B-FCF05D427E40Q37191942-DD2FA9B2-F45A-4919-BAA3-0F70133C0757Q37291653-08FD6AF0-A2B2-413E-A97D-EB8F093C395DQ37423951-DA2BAC70-4D05-4857-B88F-BF263D834B6AQ37603360-7A28B71E-C1E1-47F0-B3F2-8F65C874C03FQ37746932-A0B48826-213C-4BC2-BBF7-696CD11DC8E2Q37859842-AD2EFA25-AFE9-40E6-BC2D-A5DCEBC6A26FQ38023422-04139227-CF0A-49F9-A9F0-01E25CF6BA3DQ38067663-6DFBCB1B-97F6-414E-8289-C3F48A896C96Q38284700-84144264-4FA2-4E65-90EF-C5839A682AB4Q38618197-F904FB3F-62C0-4A93-8658-DAAD5C74DA50Q38814885-000C6D59-CAC4-46FE-80C0-4CDBEF112C15Q39181445-F38CEE54-13F4-4DDD-82BB-ECC921188988Q39302752-D569C679-2536-4792-B449-443F7B0EAE8FQ39926337-3DE6C1E0-CA7E-421C-96D2-B00BE38780CBQ40455004-816E62E4-8A27-42A4-9CA4-43CC63354A66Q45869559-8EFE4299-6A10-4FC1-BD1B-F64354F87EE2Q47549177-CEFFE842-B0C5-43DD-862A-4064BC2FFC1CQ47593481-0C376090-8F88-4FC3-83EF-EF0A524E9FD8Q54246796-34D2CD7A-1F41-416E-9890-46E3A87ED3B0Q55423899-FB0E7DCE-60BB-4336-B2EC-5589EB7B2A05
P2860
Structure-based identification of a major neutralizing site in an adenovirus hexon.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Structure-based identification of a major neutralizing site in an adenovirus hexon.
@en
Structure-based identification of a major neutralizing site in an adenovirus hexon.
@nl
type
label
Structure-based identification of a major neutralizing site in an adenovirus hexon.
@en
Structure-based identification of a major neutralizing site in an adenovirus hexon.
@nl
prefLabel
Structure-based identification of a major neutralizing site in an adenovirus hexon.
@en
Structure-based identification of a major neutralizing site in an adenovirus hexon.
@nl
P2093
P2860
P356
P1433
P1476
Structure-based identification of a major neutralizing site in an adenovirus hexon.
@en
P2093
Guang-Ping Gao
Hildegund C J Ertl
James M Wilson
Jeffrey M Bergelson
John J Rux
Mark Drinker
Roger M Burnett
Susan L Pichla-Gollon
Xiangyang Zhou
P2860
P304
P356
10.1128/JVI.02023-06
P407
P577
2006-11-15T00:00:00Z